GURAMA LTD

Company number 13005106 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

GURAMA LTD - Analysis Report

Company Number: 13005106

Analysis Date: 2025-07-20 14:19 UTC

Financial Health Assessment for GURAMA LTD as of 30 November 2024


1. Financial Health Score: D

Explanation:
GURAMA LTD’s financials reveal persistent negative net assets and working capital deficits over multiple years, indicating symptoms of financial distress. The company’s balance sheet shows a weakening ability to cover short-term obligations with current assets, a critical "vital sign" of liquidity health. Although the director has provided advances to support cash flow, the underlying financial structure remains fragile, warranting a below-average grade.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Fixed Assets 12,623 Relatively modest investment in long-term assets; slight decline from prior year.
Current Assets 17,741 Short-term assets increased, but still insufficient to cover liabilities.
Current Liabilities 41,501 High short-term debts creating a liquidity strain.
Net Current Assets (Working Capital) -23,760 Negative by £23,760, indicating inability to cover immediate liabilities with available assets.
Total Assets less Current Liabilities -11,137 Negative, showing overall asset coverage is insufficient once short-term liabilities deducted.
Creditors due after 1 year 9,253 Long-term debts also present, adding to financial burden.
Net Assets (Shareholders Funds) -20,390 Negative equity indicates accumulated losses or liabilities exceeding assets.
Director’s Loan Account 12,947 (credit) Director has injected funds to support liquidity, reflecting external symptom of cash flow stress.

3. Diagnosis: Financial Condition Overview

GURAMA LTD exhibits symptoms of financial distress:

  • Liquidity Weakness: The company’s current liabilities exceed current assets by a substantial margin, indicating an unhealthy cash position and potential difficulties meeting short-term obligations. This “unhealthy cash flow” symptom is a critical warning sign.
  • Negative Net Assets: The shareholders’ deficit of over £20,000 suggests accumulated losses or debt financing exceeding asset base, akin to a patient with weakened organ function.
  • Reliance on Director Funding: The director’s loan account credit balance acts like a temporary life-support mechanism, indicating the business depends on personal funds to sustain operations.
  • Stable but Modest Asset Base: Fixed assets have slightly decreased, suggesting no major investment or growth, possibly due to resource constraints.
  • Employee Growth vs. Financial Strain: The average number of employees rose from 15 to 22, which could be a strain on cash flow without corresponding revenue growth.

Overall, the company is in a fragile financial state with risks of cash flow shortages and insolvency pressures if current trends persist.


4. Recommendations: Steps to Improve Financial Wellness

  1. Improve Cash Flow Management:

    • Conduct a detailed cash flow forecast to identify timing gaps.
    • Accelerate receivables, optimize inventory, and negotiate extended payment terms with suppliers.
  2. Reduce Current Liabilities:

    • Prioritize repayment or restructuring of short-term debts to improve liquidity ratios.
    • Explore refinancing options to convert short-term debts into manageable long-term obligations.
  3. Strengthen Equity Base:

    • Consider capital injection from shareholders or external investors to restore positive net assets.
    • Retain earnings by controlling costs and improving profitability.
  4. Cost Control and Efficiency:

    • Review staffing and operational costs given employee growth to ensure sustainable overheads.
    • Identify non-essential expenses and reduce to relieve financial pressure.
  5. Director’s Loan Management:

    • Formalize repayment plans for director’s advances to avoid long-term liability build-up.
    • Ensure transparency and documentation to maintain trust with stakeholders.
  6. Strategic Review:

    • Evaluate business model and market positioning in the take-away food sector to identify growth opportunities or diversification.
    • Engage financial advisors for turnaround strategies if necessary.

Medical Analogy Summary

GURAMA LTD is currently operating with a "weakened heart" — its cash flow and liquidity are insufficient to meet immediate obligations, much like a patient with poor circulation struggling to supply vital organs. The persistent negative net asset position is akin to chronic illness, requiring urgent intervention to avoid critical failure. Director funding is functioning as emergency "life support," but sustainable recovery demands structural adjustments and capital strengthening.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.